MicroRNA-27a, downregulated in human obesity, exerts an antiapoptotic function in adipocytes

Lulu Liu1, Danting Li2, Chuan Peng3

  • 1Department of Gastroenterology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.

Endocrine Journal
|April 5, 2023
PubMed

Insights

MicroRNA-27a (miR-27a) levels decrease in obesity, promoting adipocyte apoptosis. Overexpressing miR-27a protects fat cells from programmed cell death, offering a potential therapeutic target for adipose tissue dysfunction.

Area of Science:

  • Molecular Biology
  • Metabolic Disorders
  • Cell Biology

Background:

  • Adipocyte apoptosis is a critical factor in adipose tissue (AT) inflammation during obesity.
  • MicroRNA-27a (miR-27a) is implicated in metabolic disorders, but its role in obese AT apoptosis is unclear.

Purpose of the Study:

  • To investigate miR-27a alterations in obese individuals.
  • To determine the antiapoptotic function of miR-27a in adipocytes.

Main Methods:

  • Collected human serum/AT and mouse epididymal fat for miR-27a expression analysis.
  • Induced adipocyte apoptosis using TNF-α in vitro.
  • Overexpressed miR-27a-3p using transfection and assessed apoptosis markers (caspase 3/8, Bax/Bcl-2 ratio, TUNEL, Hoechst staining).

Main Results:

  • miR-27a was significantly downregulated in serum and AT of obese humans and in high-fat diet-fed mice.
  • Serum miR-27a levels correlated with metabolic parameters in human obesity.
  • miR-27a overexpression attenuated TNF-α-induced adipocyte apoptosis, reducing cleaved caspase 3/8 and altering Bax/Bcl-2 ratio.

Conclusions:

  • miR-27a is downregulated in obese adipose tissue, correlating with a proapoptotic state.
  • Overexpression of miR-27a demonstrates an antiapoptotic effect in adipocytes.
  • miR-27a represents a potential therapeutic target for preventing adipose tissue dysfunction in obesity.